A patient-centered, combination intervention to support adherence to HIV pre-exposure prophylaxis during pregnancy and breastfeeding: a randomized pilot study in Malawi
The intervention was integrated Next Step Counseling to identify relevant needs and help participants generate their own solutions for improving, facilitating, and sustaining well-being, sexual health, and drug adherence, as well as optional engagement of an adherence supporter. Study retention remained high at both three months and six months after initiation. There were no significant differences of adherence between the intervention group and control groups at three months or six months. Fewer than 1/3 of participants had confirmed adherence of >=4 doses/week.
Resource Details
- Study Type
- Pilot study, Randomized clinical trial (RCT)
- Year
- 2024
- Population
- HIV-uninfected women, Pregnant Women
- Author
- Chi BH, Saidi F, Graybill LA, Phanga T, Mollan KR, Amico KR, Freeborn K, Rosenberg NE, Hill LM, Hamoonga T, Richardson B, Kalua T, Phiri S, Mutale W.
More Publications & Resources
Providing PrEP to Pregnant and Breastfeeding Women
Clinical Practice Guidelines for Providing PrEP for Pregnant and Breastfeeding Populations
Guidelines on Lenacapavir for HIV Prevention and Testing Strategies for Long-Acting Injectable Pre-Exposure Prophylaxis
PrEP and PEP Guidelines-Zambia
PrEP Lenacapavir Implementation Guidelines
Provider Training Toolkit on Use of Oral and Long-acting HIV PrEP: Lenacapavir-Focused Learning Pathway (Lessons 1-4)
Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP
Inclusion of Pregnant and Lactating People in the PURPOSE 1 Study: Efficacy, Safety, and Pharmacokinetics
Lenacapavir Provider Tools and Job Aids
PrEP Drug Interactions
Zambia PrEP Training Materials for Clinicians and Community Mobilisers
No results found.